Based on these findings, we assume that increased BCL6 expression may be an adaptive surge in the cellular response to oncogene- or nononcogene-induced stress, highlighting the multifaceted role of BCL6 in cancer and the broad application of BCL6-based therapy. This evidence concerns the gene BCL6 and cancer.